Target Name: LOC105378486
NCBI ID: G105378486
Review Report on LOC105378486 Target / Biomarker Content of Review Report on LOC105378486 Target / Biomarker
LOC105378486
Other Name(s): LOC105378486 variant X2 | Uncharacterized LOC105378486, transcript variant X2

LOC105378486 variant X2: A protein involved in neurodegenerative diseases

LOC105378486 (LOC105378486 variant X2) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the T-cell antigen 6 (TCA6) family, which is a group of glycoproteins that are involved in the immune response.

LOC105378486 variant X2 is characterized by a single amino acid substitution at its C-terminus, which results in a change from Asp to Glu. This substitution has affected the stability and function of the protein, leading to its decreased stability and increased aggregation in the brain.

The decreased stability and aggregation of LOC105378486 variant X2 in the brain make it an attractive drug target. The brain is a sensitive target for drugs because of its high metabolic activity and the presence of a large number of blood vessels, which can make it difficult to deliver drugs efficiently. Additionally, the brain is home to a diverse array of cell types that are involved in various physiological processes, making it difficult to predict the effects of drugs on a wide range of cell types.

LOC105378486 variant X2 has been shown to play a role in the development and progression of a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Studies have shown that LOC105378486 variant X2 is involved in the formation of neurofibrillary tangles and neuroglial cells in the brain, which are thought to contribute to the development of these diseases.

In addition to its role in neurodegenerative diseases, LOC105378486 variant X2 has also been shown to be involved in various physiological processes in the brain, including cell signaling, neurotransmitter release, and synaptic plasticity. This makes it an attractive target for drugs that are designed to modulate brain function or protect against neurodegeneration.

LOC105378486 variant X2 has also been shown to be involved in the immune response, which is another potential drug target. The T-cell antigen 6 (TCA6) family is involved in the development and regulation of immune cell function, and LOC105378486 variant X2 has been shown to play a role in the regulation of T-cell function.

In conclusion, LOC105378486 variant X2 is a promising drug target for a variety of neurodegenerative diseases. Its decreased stability and aggregation in the brain make it an attractive target for small molecules that can modulate brain function or protect against neurodegeneration. Additionally, its involvement in the immune response makes it a potential target for drugs that are designed to modulate immune cell function. Further research is needed to fully understand the role of LOC105378486 variant X2 in the development and progression of neurodegenerative diseases, and to identify potential drugs that can modulate its function.

Protein Name: Uncharacterized LOC105378486, Transcript Variant X2

The "LOC105378486 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378486 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660